Monica Donnola

Title: Monica Donnola: Innovator in Pharmaceutical Synthesis

Introduction

Monica Donnola is a prominent inventor based in Novara, Italy. She has made significant contributions to the field of pharmaceutical synthesis, holding 2 patents that showcase her innovative approaches to chemical processes. Her work focuses on developing cost-effective and scalable methods for synthesizing important pharmaceutical compounds.

Latest Patents

Monica's latest patents include a process for the synthesis of lofexidine and a process for the synthesis of 2-benzhydryl-3-quinuclidinone. The lofexidine synthesis process involves using ethyl 2-(2,6-dichlorophenoxy)propionate and ethylenediamine in the presence of tetravalent titanium alkoxides. This method is designed to be more cost-effective and easily scalable compared to existing procedures. The second patent details a process for preparing 2-benzhydryl-3-quinuclidinone through the reaction of 2-benzylidene-3-quinuclidinone with phenyl-magnesium halide in the presence of copper (I) salts. This innovative approach allows for higher yields and utilizes less toxic solvents.

Career Highlights

Monica Donnola is currently employed at Procos S.p.a., where she continues to advance her research in pharmaceutical synthesis. Her work has not only contributed to the field but has also positioned her as a key player in the industry.

Collaborations

Monica collaborates with notable colleagues such as Jacopo Roletto and Paolo Paissoni, enhancing her research through teamwork and shared expertise.

Conclusion

Monica Donnola's innovative contributions to pharmaceutical synthesis demonstrate her commitment to advancing the field through effective and scalable processes. Her patents reflect her expertise and dedication to improving pharmaceutical manufacturing.